GOT1 and familial pancreatic carcinoma: AO was further reported to competitively bind to and form a complex with cCAT, inhibiting its intracellular activity and, thus, targeting glutamine metabolism activity in pancreatic cancer cells [164], essential to sustain their proliferation and support tumor growth, as mentioned above [76].